Diabetes (Type 1)

This study aims to determine the safety and feasibility of a tablet called empagliflozin to treat type 1 diabetes soon after it is diagnosed.

 

Trial phase 

check
Observational
Phase 1
Phase 2
Phase 3
Phase 4
Multiple sclerosis

The purpose of this study is to assess the effectiveness and safety of commonly used doses of Botulinum toxin (Botox) on arm shaking (or tremor) in people with multiple sclerosis (MS).

Trial phase 

check
Observational
Phase 1
Phase 2
Phase 3
Phase 4
Colitis

The purpose of this study is to determine whether etrolizumab is a safe and effective treatment for ulcerative colitis in patients with moderately to severely active ulcerative colitis who have previously been treated with a class of drugs called tumour necrosis factor (TNF) inhibitors, which affects the inflammatory response of your body, but unsuccessfully.

Trial phase 

check
Observational
Phase 1
Phase 2
Phase 3
Phase 4
Multiple sclerosis

The research project is testing a safe new treatment for muscle spasticity and spasms/cramps in people with multiple sclerosis (MS). 

Trial phase 

check
Observational
Phase 1
Phase 2
Phase 3
Phase 4
Epilepsy

This project is an international collaboration between clinical trial centres within the United States of America, Canada, Austria, Ireland and Australia and is overseen by The Epilepsy Study Consortium in the United States of America. The purpose of the project is to monitor the course of treatment for those who have recently been diagnosed with focal epilepsy. 

Trial phase 

check
Observational
Phase 1
Phase 2
Phase 3
Phase 4
Diabetes (Type 2)

The purpose of the FIGARO-DKD clinical research study is to evaluate whether adding an investigational medication called finerenone to regular treatment is safe and effective to help reduce cardiovascular complications like heart disease or stroke in patients with type 2 diabetes and diabetic kidney disease.

Trial phase 

check
Observational
Phase 1
Phase 2
Phase 3
Phase 4
Diabetes (Type 2)

This pilot study aims to evaluate how well the combination of Coenzyme Q10, Magnesium orotate and thiamine, works as a treatment for painful peripheral neuropathy.

Trial phase 

check
Observational
Phase 1
Phase 2
Phase 3
Phase 4
Colitis

The purpose of this study is to determine whether etrolizumab is a safe and effective treatment in patients with moderate to severe active ulcerative colitis that have previously had an unsuccessful response to treatment with immunosuppressants (aka TNF inhibitors - medications that reduces the activation or efficacy of the immune system) such as azathioprine, 6-mercaptopurine, or methotrexate and/or corticosteroids and to see whether etrolizumab is more effective than adalimumab in treating ulcerative colitis. Adalimumab is approved by the Therapeutic Goods Administration in Australia for

Trial phase 

check
Observational
Phase 1
Phase 2
Phase 3
Phase 4